A modular analyzer system for double antibody radioimmunoassays

Peer Reviewe

Crop residue application increases nitrogen fixation and dry matter production in groundnut (Arachis hypogaea L.) grown on an acid sandy soil in Niger, West Africa

Field experiments were conducted during the rainy reasons of 1989, 1990 and 1991 on an acid sandy soil in Niger, West Africa, to assess the effect of millet straw application (+CR) on growth and N2 fixation of groundnut (Arachis hypogaea L.). Three years of +CR (4 t ha−1 yr−1) increased symbiotic N2 fixation, total dry matter production (haulm plus pods) by 83% and total nitrogen (N) accumulation by 100%. Concentration of N in the shoot dry matter and total N in the soil were only slightly affected by the +CR treatment. Crop residue application increased the concentration of potassium (K) and molybdenum (Mo) and decreased the concentrations of aluminium (Al) and manganese (Mn) distinctly, both in the plant (shoot and nodule dry matter) and in the soil. The increase in dry matter production and N uptake was mainly due to improved N2 fixation reflected by enhanced formation and growth of nodules as well as nitrogenase activity. This was attributed to improved chemical soil conditions, particularly to the higher availability of Mo and the lowered content of available Al and Mn. Although with the application of 4 t CR ha−1, 60 kg K were supplied, increased growth could not be attributed to the additional supply of K

Vanadium (β-(Dimethylamino)ethyl)cyclopentadienyl Complexes with Diphenylacetylene Ligands

Reduction of the V(III) (β-(dimethylamino)ethyl)cyclopentadienyl dichloride complex [η5:η1-C5H4(CH2)2NMe2]VCl2(PMe3) with 1 equiv of Na/Hg yielded the V(II) dimer {[η5:η1-C5H4(CH2)2NMe2]V(µ-Cl)}2 (2). This compound reacted with diphenylacetylene in THF to give the V(II) alkyne adduct [η5:η1-C5H4(CH2)2NMe2]VCl(η2-PhC≡CPh). Further reduction of 2 with Mg in the presence of diphenylacetylene resulted in oxidative coupling of two diphenylacetylene groups to yield the diamagnetic, formally V(V), bent metallacyclopentatriene complex [η5:η1-C5H4(CH2)2NMe2]V(C4Ph4).

Arsenic hyperaccumulation by different fern species

Pteris vittata was the first identified arsenic (As) hyperaccumulator. Our aim was to test whether As hyperaccumulation occurs in other fern species, and whether P. vittata collected from both contaminated and uncontaminated environments accumulates As similarly. Three accessions of P. vittata, two cultivars of Pteris cretica, Pteris longifoliaandPteris umbrosa were grown with 0-500 mg As kg(-1) added to the substrate. A second experiment compared As uptake by five common ferns obtained from commercial suppliers. The results show that, in addition to P. vittata, P. cretica, P. longifolia and P. umbrosa also hyperaccumulate As to a similar extent. There was little difference between different Pteris species, or between different accessions of P. vittata. By contrast, Asplenium nidus , Davallia canarensis, Polypodium aureum, Polystichum tsus-simense do not hyperaccumulate As. This study identified three new species of As hyperaccumulators in the Pteris genus and suggests that As hyperaccumulation is a constitutive property in P. vittata

Estimating the number needed to treat from continuous outcomes in randomised controlled trials: methodological challenges and worked example using data from the UK Back Pain Exercise and Manipulation (BEAM) trial

Background Reporting numbers needed to treat (NNT) improves interpretability of trial results. It is unusual that continuous outcomes are converted to numbers of individual responders to treatment (i.e., those who reach a particular threshold of change); and deteriorations prevented are only rarely considered. We consider how numbers needed to treat can be derived from continuous outcomes; illustrated with a worked example showing the methods and challenges. Methods We used data from the UK BEAM trial (n = 1, 334) of physical treatments for back pain; originally reported as showing, at best, small to moderate benefits. Participants were randomised to receive 'best care' in general practice, the comparator treatment, or one of three manual and/or exercise treatments: 'best care' plus manipulation, exercise, or manipulation followed by exercise. We used established consensus thresholds for improvement in Roland-Morris disability questionnaire scores at three and twelve months to derive NNTs for improvements and for benefits (improvements gained+deteriorations prevented). Results At three months, NNT estimates ranged from 5.1 (95% CI 3.4 to 10.7) to 9.0 (5.0 to 45.5) for exercise, 5.0 (3.4 to 9.8) to 5.4 (3.8 to 9.9) for manipulation, and 3.3 (2.5 to 4.9) to 4.8 (3.5 to 7.8) for manipulation followed by exercise. Corresponding between-group mean differences in the Roland-Morris disability questionnaire were 1.6 (0.8 to 2.3), 1.4 (0.6 to 2.1), and 1.9 (1.2 to 2.6) points. Conclusion In contrast to small mean differences originally reported, NNTs were small and could be attractive to clinicians, patients, and purchasers. NNTs can aid the interpretation of results of trials using continuous outcomes. Where possible, these should be reported alongside mean differences. Challenges remain in calculating NNTs for some continuous outcomes